Celestica (TSE:CLS – Get Free Report) (NYSE:CLS) was upgraded by equities research analysts at BNP Paribas to a “strong-buy” rating in a research report issued to clients and investors on Wednesday,Zacks.com reports.
Several other analysts also recently commented on the stock. Argus raised shares of Celestica to a “strong-buy” rating in a report on Tuesday, April 29th. Canaccord Genuity Group reduced their target price on shares of Celestica from C$138.00 to C$126.00 and set a “buy” rating for the company in a report on Monday, April 28th. Finally, BMO Capital Markets reduced their price objective on Celestica from C$140.00 to C$118.00 in a report on Monday, April 28th. One equities research analyst has rated the stock with a hold rating, two have given a buy rating and four have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, Celestica currently has a consensus rating of “Buy” and a consensus target price of C$110.50.
View Our Latest Stock Report on CLS
Celestica Trading Up 2.0%
Celestica Company Profile
Celestica Inc provides supply chain solutions in North America, Europe, and Asia. It operates through two segments: Advanced Technology Solutions, and Connectivity & Cloud Solutions. The company offers a range of product manufacturing and related supply chain services, including design and development, new product introduction, engineering services, component sourcing, electronics manufacturing and assembly, testing, complex mechanical assembly, systems integration, precision machining, order fulfillment, logistics, asset management, product licensing, and after-market repair and return services.
See Also
- Five stocks we like better than Celestica
- Are Penny Stocks a Good Fit for Your Portfolio?
- Ignore the Noise—Samsara Stock Is Still a Strong Buy
- What is a support level?
- 3 Stocks Set to Double—And There’s Still Time to Buy
- 3 Stocks to Consider Buying in October
- Analysts Can’t Get Enough of These Little-Known Biopharma Stocks
Receive News & Ratings for Celestica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celestica and related companies with MarketBeat.com's FREE daily email newsletter.